The three pillars of Diabeter’s research
Type 1 diabetes is a heterogeneous disease. Our research aims to dissect this heterogeneity in order to develop the best personal prediction, personal prevention and personal treatment. In this short video, Dr Dick Mul provides a quick guide to some of Diabeter’s clinical research activities and priorities with some major projects of our research:
As Dr Mul explains in the video below, the ultimate aim is to translate study findings into real improvements in clinical practice, and optimise the care of all patients.